Durafiber Ag

Dressings in gelling fibers of ethyl sulphonated cellulose with silver

Dressing belonging to a new generation of gelling cellulose fibers, designed to meet the many challenges posed by infected or non-infected medium to heavy exudate wounds.

The high integral wet strength DURAFIBER Ag facilitates the removal of a piece of moist wound bed and cavity wounds thereby minimizing trauma to the wound and pain for the patient upon removal.

Indications

DURAFIBER Ag is indicated as an absorbent, gelling antimicrobial dressing for the management of chronic and acute full thickness, partial thickness, or superficial granulation exuding wounds. For example: ulcers of the lower limbs; pressure ulcers; diabetic ulcers; surgical wounds; traumatic wounds; donor sites; partial thickness burns; injured tunneling and fistulas; wounds left to heal by secondary intention; and wounds that are prone to bleeding such as wounds that have been surgically or mechanically cleaned.

DURAFIBER Ag is designed to be left in place for up to 7 days.

DURAFIBER Ag can be used on infected wounds. If the product is used on infected wounds the infection should be inspected and treated according to local protocol.

Contraindications

• Do not use on patients with known hypersensitivity to silver.
• Do not use on wounds does not ooze.

Precautions

• Physicians / healthcare professionals should be aware that there is very limited data on the prolonged and repeated use of silver containing condiments, particularly in children and infants.
• While DURAFIBER Ag assists in the management of wounds at risk of minor bleeding, it is not intended to be used as a surgical sponge in heavily bleeding wounds.
• DURAFIBER Ag is not compatible with oil-based products such as petroleum jelly.
• Avoid contact with conductive electrodes or gels during electronic measurements such as EEG and ECG.
• Make sure the packing in sinus cavities etc has been removed.
• The dressing may not be compatible with topical antimicrobials.If redness or sensitization occurs discontinue use.In the event of clinical infection, topical silver does not replace the need for systemic therapy or other treatment of adequate infection.
• When DURAFIBER Ag is used on a patient during MRI (Magnetic Resonance Imaging) examination some warming may be experienced.
• DURAFIBER Ag can cause transient discoloration of the surrounding skin.

Instructions for Use

1. Cleanse the wound according to local clinical protocol.
2. Select the correct dressing room format.
3. Remove the DURAFIBER Ag dressing from the pack, using a clean technique. Cut into shape as needed.
4. Apply the dressing to the wound and allow a 1cm / 1 / 3in.dressing overlap on the skin surrounding the wound.
5. When using DURAFIBER Ag in deep cavity wounds use full dressings wherever possible and leave at least 2.5cm / 1in. of each piece outside the wound for easy retrieval.
6. Loosely pack deep wounds up to 80% capacity, as DURAFIBER Ag will expand upon contact with wound fluid.
7. Secure DURAFIBER Ag with a moisture retention dressing (e.g. ALLEVYN / Opsite) or other appropriate secondary retention.
8. The dressing can be removed in one piece using sterile tweezers, forceps or a gloved hand.
9. The dressing may adhere when used on lightly exuding wounds. If the dressing is not easily removed, moisten or soak the dressing in sterile saline to aid removal and avoid disruption of wound healing.

During the early stages of wound management, DURAFIBER dressings should be checked frequently. Dressings can be left undisturbed for up to 7 days or changed when clinically indicated, (for example, if leakage, excessive bleeding is present). Local clinical protocol should also be considered. DURAFIBER Ag is a single use product. If used on more than one patient, cross-contamination or infection can result. Opening the dressing package compromises the sterile barrier. Any unused dressing should be discarded.

Format

Pack with 10 dressings. Measure 10x10cm.